(Q34673385)

3 August 2017

1 reference

title

Genes and their polymorphisms in mono- and multifactorial cardiomyopathies: towards pharmacogenomics in heart failure (English)

1 reference

3 August 2017

1 reference

1 reference

Philippe Charron

1

0 references

Michel Komajda

series ordinal

2

object named as

Michel Komajda

1 reference

3 August 2017

publication date

1 May 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

3

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

367-378

1 reference

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

The Frequency of Familial Dilated Cardiomyopathy in a Series of Patients with Idiopathic Dilated Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Familial dilated cardiomyopathy in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Familial dilated cardiomyopathy: clinical features in French families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Familial aggregation of idiopathic dilated cardiomyopathy: clinical features and pedigree analysis in 14 families

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Prevalence and characteristics of dystrophin defects in adult male patients with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Gene mapping of familial autosomal dominant dilated cardiomyopathy to chromosome 10q21-23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Dilated cardiomyopathy and sensorineural hearing loss: a heritable syndrome that maps to 6q23-24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Linkage of familial dilated cardiomyopathy with conduction defect and muscular dystrophy to chromosome 6q23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

The Genetic Basis for Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Complexity in simplicity: monogenic disorders and complex cardiomyopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Actin mutations in dilated cardiomyopathy, a heritable form of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Desmin mutation responsible for idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Epidemiology of desmin and cardiac actin gene mutations in a european population of dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

A new locus for autosomal dominant dilated cardiomyopathy identified on chromosome 6q12-q16

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Polymorphisms in the SOD2 and HLA-DRB1 genes are associated with nonfamilial idiopathic dilated cardiomyopathy in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Beta1-adrenoceptor gene variations: a role in idiopathic dilated cardiomyopathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Haemochromatosis gene mutations in idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Idiopathic dilated cardiomyopathy: lack of association with haemochromatosis gene in the CARDIGENE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Characterization of the human nebulette gene: a polymorphism in an actin-binding motif is associated with nonfamilial idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

The Ile164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

A novel polymorphism in the gene coding for the beta(1)-adrenergic receptor associated with survival in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

A polymorphism in the endothelin-A receptor gene predicts survival in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Pharmacogenetics of beta-1- and beta-2-adrenergic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Polymorphisms of the beta(2)-adrenergic receptor determine exercise capacity in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Blunted cardiac responses to receptor activation in subjects with Thr164Ile beta(2)-adrenoceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-mode and two-dimensional echocardiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

The molecular genetic basis for hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Familial hypertrophic cardiomyopathy: from mutations to functional defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Association of a G994 --> T (Val279 --> Phe) polymorphism of the plasma platelet-activating factor acetylhydrolase gene with myocardial damage in Japanese patients with nonfamilial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

New concepts in hypertrophic cardiomyopathies, part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Application of industrial scale genomics to discovery of therapeutic targets in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Functional genomics and cardiovascular drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Investigation of a family with autosomal dominant dilated cardiomyopathy defines a novel locus on chromosome 2q14-q22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Idiopathic Dilated Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Restrictive Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Lack of association between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Human gene for physical performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Characterization of a Unique Genetic Variant in the β1-adrenoceptor Gene and Evaluation of its Role in Idiopathic Dilated Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

Identification of a genetic risk factor for idiopathic dilated cardiomyopathy. Involvement of a polymorphism in the endothelin receptor type A gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.3.3.367

21 January 2018

Identifiers

DOI

10.1517/14622416.3.3.367

1 reference

3 August 2017

1 reference